TTFields Synergistic Combinations for Enhanced Tumor Treatment

Publication ID: 24-11857782_0008_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “TTFields Synergistic Combinations for Enhanced Tumor Treatment,” Published Technical Disclosure No. 24-11857782_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857782_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,782.

Summary of the Inventive Concept

The inventive concept integrates the patented implantable transducer arrays for delivering TTFields with distinct technologies like AI, IoT, blockchain, and new materials to create a more powerful system for treating tumors, enhancing treatment efficacy and patient outcomes.

Background and Problem Solved

The original Optune system for delivering TTFields has limitations, such as requiring transducer arrays to be placed on the patient's skin, which can be uncomfortable and may not provide optimal treatment. The new inventive concept addresses these limitations by integrating implantable transducer arrays with advanced technologies to create a more effective and patient-centric system.

Detailed Description of the Inventive Concept

The new system comprises an implantable transducer array, which delivers TTFields to the tumor, and is integrated with an AI module that optimizes TTFields delivery based on patient-specific data. The system also includes a blockchain-based secure data storage module, an IoT-enabled sensor module for real-time tracking, and a cloud-based analytics platform for data analysis and insights. Furthermore, the system utilizes machine learning algorithms to generate a 3D model of the tumor, adjusting TTFields delivery in real-time. Additionally, the system incorporates new material-based transducer arrays with enhanced electrical conductivity, enabling more efficient TTFields delivery.

Novelty and Inventive Step

The new inventive concept's integration of distinct technologies with implantable transducer arrays for delivering TTFields is novel and non-obvious, providing a synergistic combination that enhances treatment efficacy and patient outcomes. The use of AI, IoT, blockchain, and new materials in this context is unprecedented and provides a significant inventive step over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating the implantable transducer arrays with other advanced technologies, such as robotics or nanotechnology, to further enhance treatment outcomes. Variations could also include adapting the system for treating different types of tumors or diseases, or developing miniaturized versions of the implantable transducer arrays for increased patient comfort.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the fields of oncology and neurology. The system's ability to enhance treatment efficacy and patient outcomes could lead to widespread adoption in hospitals and clinics, providing a substantial market opportunity.

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Biomedical engineering, specifically medical device technologies for tumor treatment using electromagnetic fields, requiring advanced knowledge of electrical engineering, medical device design, and signal processing

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in medical device design, electrical engineering, signal processing, and advanced medical technologies, holding at least a master's degree with 3-5 years of specialized experience in medical device innovation

Obviousness Rationale

A PHOSITA would recognize that integrating advanced digital technologies like AI, IoT, and machine learning with existing TTFields delivery systems represents a predictable and logical extension of the source patent's core technology. The fundamental approach of optimizing electromagnetic field delivery for tumor treatment remains consistent, with the PTD merely adding computational and data-driven enhancements to the existing implantable transducer array concept. These technological integrations would be considered routine optimization strategies for improving medical device performance and patient outcomes.

Obvious Combinations & Variations

Source Patent Element

Implantable electrode arrays for delivering tumor treating fields

PTD Variation

Adding AI module for real-time TTFields delivery optimization

Obviousness Reasoning

Applying machine learning to medical device performance is a known technique for improving treatment precision, representing a predictable application of computational methods to existing medical technologies

Source Patent Element

Temperature sensors integrated with electrode elements

PTD Variation

IoT-enabled sensor module for real-time tracking and data transmission

Obviousness Reasoning

Extending sensor capabilities to remote monitoring is a standard design evolution in medical device technologies, offering enhanced patient data collection through well-established communication protocols

Source Patent Element

Capacitively coupled electrode elements

PTD Variation

New material-based transducer arrays with enhanced electrical conductivity

Obviousness Reasoning

Material science improvements to electrode performance represent an obvious iterative design approach, with finite known methods for enhancing electrical signal transmission

Source Patent Element

Implantable transducer arrays for electromagnetic field delivery

PTD Variation

3D tumor modeling using machine learning for adaptive TTFields delivery

Obviousness Reasoning

Applying computational modeling to medical treatment optimization is a predictable application of existing machine learning techniques to personalized medical interventions

Source Patent Element

Electrode arrays configured for implantation within a person's body

PTD Variation

Blockchain-based secure data storage for patient treatment information

Obviousness Reasoning

Implementing secure data management techniques is a standard design consideration for medical technologies, representing an obvious enhancement to existing medical device systems

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857782 and the disclosed variations, a person of ordinary skill in the art would find the proposed technical combinations obvious and lacking inventive step. The integration of computational technologies with implantable TTFields delivery systems represents a predictable application of known techniques to existing medical device architectures, thereby rendering potential claims covering such variations unpatentable under 35 U.S.C. § 103.

Original Patent Information

Patent Number	US 11,857,782
Title	Delivering tumor treating fields (TTFields) using implantable transducer arrays
Assignee(s)	Novocure GmbH